Putting research into context-revisited

The Lancet

Volumn 376, Issue 9734, 2010, Pages 10-11

  Clark, Stephanie ^a   Horton, Richard ^a  

^a THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; HEALTH CARE; NOTE; PRIORITY JOURNAL; RESEARCH; CLINICAL TRIAL; LITERATURE; PUBLISHING; STANDARD;

CLINICAL TRIALS AS TOPIC; EDITORIAL POLICIES; PUBLISHING; REVIEW LITERATURE AS TOPIC;

EID: 77954708521     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61001-X     Document Type: Note

References (5)

1. Young C, Horton R. Putting clinical trials into context. Lancet 2005; 366: 107-108
2. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials; the CONSORT statement. JAMA 1996; 276: 637-639
3. Clarke M, Hopewell S, Chalmers I. Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 2010; 376: 20-21.
4. Anon. The CONSORT statement. April 20, 2010. http://www.consortstatement. org/consort-statement/overview0 (accessed June 21, 2010).
5. Ellis P, Barrett-Lee P, Johnson L, et al, for the TACT Trial Management Group for the TACT Trialists. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial. Lancet 2009; 373: 1681-1692